Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab with or without radiotherapy in operable localized soft tissue sarcoma
2016-005019-42Phase 2Active
- Sponsor
- Centre Léon Bérard
- Start
- Dec 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in soft tissue sarcoma (STS), sponsored by Centre Léon Bérard. Started Dec 2017; status: active.
02
Drugs
atezolizumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2016-005019-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005019-42.